Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects

Mise à jour : Il y a 4 ans
Référence : NCT01516307

Femme Homme

Extrait

The purpose of this study is to compare active immunotherapy (OPT-822/OPT-821) with PBS in combination with low dose cyclophosphamide, in post-treated metastatic breast cancer subjects with stable disease or response to treatment.


Critère d'inclusion

  • Metastatic breast cancer


Liens